Resultats de la cerca - Michael A. Statnick
- Mostrar 1 - 15 resultats de 15
-
1
-
2
-
3
-
4
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction per Marsida Kallupi, Giulia Scuppa, Giordano de Guglielmo, Girolamo Caló, Friedbert Weiss, Michael A. Statnick, Linda M. Rorick‐Kehn, Roberto Ciccocioppo
Publicat 2016Artigo -
5
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence per Jeffrey M. Witkin, Michael A. Statnick, Linda M. Rorick‐Kehn, John E. Pintar, Michael Ansonoff, Yanyun Chen, R. Craig Tucker, Roberto Ciccocioppo
Publicat 2013Revisão -
6
Cloning of a Human Receptor of the NPY Receptor Family with High Affinity for Pancreatic Polypeptide and Peptide YY per Ingrid Lundell, Anders Blomqvist, Magnus Berglund, Douglas A. Schober, D. Brooke Johnson, Michael A. Statnick, Robert A. Gadski, Donald R. Gehlert, Dan Larhammar
Publicat 1995Artigo -
7
-
8
The Thermogenic Effect of Leptin Is Dependent on a Distinct Population of Prolactin-Releasing Peptide Neurons in the Dorsomedial Hypothalamus per Garron T. Dodd, Amy A. Worth, Nicolas Nunn, Aaron K. Korpal, David A. Bechtold, Margaret B. Allison, Martin G. Myers, Michael A. Statnick, Simon M. Luckman
Publicat 2014Artigo -
9
Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of HumansWith Type 2 Diabetes per Michael A. Statnick, Lisa S. Beavers, Laura J. Conner, Helena Corominola, D. Brooke Johnson, Craig D. Hammond, Ronit Rafaeloff-Phail, Thomas Seng, Todd M. Suter, James P. Sluka, Éric Ravussin, Robert A. Gadski, F. José
Publicat 2000Artigo -
10
Synthesis and Evaluation of Radioligands for Imaging Brain Nociceptin/Orphanin FQ Peptide (NOP) Receptors with Positron Emission Tomography per Victor W. Pike, Karen Rash, Zhaogen Chen, Concepción Pedregal, Michael A. Statnick, Yasuyuki Kimura, Jinsoo Hong, Sami S. Zoghbi, Masahiro Fujita, Miguel A. Toledo, Nuria Cirauqui, Susan L. Gackenheimer, J. Tauscher, Vanessa N. Barth, Robert B. Innis
Publicat 2011Artigo -
11
Erratum: A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies per Anke Post, Trevor Smart, Judith Krikke-Workel, Gerard R. Dawson, Catherine J. Harmer, Michael Browning, Kimberley Jackson, Rishi Kakar, Richard C. Mohs, Michael A. Statnick, Keith A. Wafford, Andrew McCarthy, Vanessa N. Barth, Jeffrey M. Witkin
Publicat 2016Errata/Corrigenda -
12
A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies per Anke Post, Trevor Smart, Judith Krikke-Workel, Gerard R. Dawson, Catherine J. Harmer, Michael Browning, Kimberley Jackson, Rishi Kakar, Richard C. Mohs, Michael A. Statnick, Keith A. Wafford, Andrew McCarthy, Vanessa N. Barth, Jeffrey M. Witkin
Publicat 2015Artigo -
13
A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models per Linda M. Rorick‐Kehn, Roberto Ciccocioppo, Conrad J. Wong, Jeffrey M. Witkin, A. MARTINEZ‐GRAU, Serena Stopponi, Benjamin L. Adams, Jason Katner, Kenneth W. Perry, Miguel A. Toledo, Nuria Cirauqui, Celia Lafuente, Alma Jiménez, Ana Benito, Concepción Pedregal, Friedbert Weiss, Michael A. Statnick
Publicat 2016Artigo -
14
Functional immune mapping with deep-learning enabled phenomics applied to immunomodulatory and COVID-19 drug discovery per Michael F. Cuccarese, Berton Earnshaw, Katie Heiser, Ben Fogelson, Chadwick T. Davis, Peter McLean, Hannah Gordon, Kathleen-Rose Skelly, Fiona L. Weathersby, Vlad Rodic, Ian K. Quigley, Elissa D. Pastuzyn, Brandon M. Mendivil, Nathan H. Lazar, Carl Brooks, Joseph Carpenter, Brandon Probst, Pamela Jacobson, Seth W. Glazier, Jes Ford, James Jensen, Nicholas D. Campbell, Michael A. Statnick, Adeline S. Low, Kirk R. Thomas, Anne E. Carpenter, Sharath S. Hegde, Ronald W. Alfa, Mason Victors, Imran S. Haque, Yolanda Chong, Christopher C. Gibson
Publicat 2020Pré-impressão -
15
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis per Kjell Svensson, Beverly A. Heinz, John M. Schaus, James P. Beck, Junliang Hao, Joseph H. Krushinski, Matthew R. Reinhard, Michael P. Cohen, Sarah L. Hellman, Brian G. Getman, Xushan Wang, Michelle M. Menezes, Deanna L. Maren, Julie F. Falcone, Wesley H. Anderson, Rebecca A. Wright, Stéphanie Morin, Kelly L. Knopp, Benjamin L. Adams, Borys Rogovoy, Ilya Okun, Todd M. Suter, Michael A. Statnick, Donald R. Gehlert, David L. Nelson, Virginia L. Lucaites, Renee Emkey, Neil W. DeLapp, Todd R. Wiernicki, Jeffrey W. Cramer, Charles R. Yang, Robert F. Bruns
Publicat 2016Artigo
Eines de cerca:
Matèries relacionades
Medicine
Receptor
Internal medicine
Biology
Pharmacology
Opioid
Endocrinology
Chemistry
Nociceptin receptor
Opioid peptide
Psychology
Agonist
Drug
NOP
Neuroscience
Antagonist
Anxiety
Biochemistry
Genetics
Neuropeptide
Pathology
Psychiatry
Addiction
Adipose tissue
Antidepressant
Bioinformatics
Cell biology
Computational biology
Computer science
Disease